USA v. Shkreli et al

  1. September 07, 2017

    Feds Want Shkreli's Bail Revoked Over Clinton 'Threat'

    Prosecutors on Thursday asked a Brooklyn federal judge to revoke Martin Shkreli's bail in the wake of his conviction for securities fraud, saying the controversial former pharmaceutical executive's bizarre threat to former Secretary of State Hillary Clinton and other behavior represent a risk to the public.

  2. August 29, 2017

    Feds Say Shkreli Verdict Is No Escape For Ex-Katten Atty

    A former Katten Muchin Rosenman LLP attorney trying to gut a criminal case alleging he helped Martin Shkreli pull off multiple fraud schemes recently got pushback from federal prosecutors, who said the lawyer cannot dodge a conspiracy count just because Shkreli was acquitted of it.

  3. August 21, 2017

    Ex-Katten Atty Says Shkreli Verdict Nixes Conspiracy Count

    Lawyers for Evan Greebel, the former Katten Muchin Rosenman LLP attorney accused of helping Martin Shkreli pull off securities fraud, said Friday they were "shocked and dismayed" prosecutors haven't dropped a conspiracy charge against Greebel that Shkreli himself was acquitted of earlier this month.

  4. August 11, 2017

    News Outlets Ask Shkreli Trial Judge For Juror Names

    An attorney for Bloomberg, The Associated Press, Reuters, The New York Times Co., Daily News LP and NYP Holdings asked a New York federal judge on Friday to release the names of jury members who convicted controversial former pharmaceutical executive Martin Shkreli on two counts of securities fraud and another conspiracy charge.

  5. August 07, 2017

    Shkreli's Brazen Defiance May Lead To Harsher Sentence

    Public statements from former Turing Pharmaceuticals and Retrophin CEO Martin Shkreli deriding the prosecution's securities fraud case against him may come back to bite him at sentencing, legal experts said Monday.

  6. August 04, 2017

    Shkreli Convicted On 3 Counts In Securities Fraud Trial

    A Brooklyn federal jury on Friday convicted controversial former pharmaceutical executive Martin Shkreli on charges of defrauding investors in his ailing hedge funds and conspiring to drain drugmaker Retrophin's assets to pay off his debts.

  7. August 01, 2017

    Shkreli Jury Asks Judge About 'Fraudulent Intent'

    The Brooklyn federal jury deliberating fraud charges against Martin Shkreli came up for air after 12 solid hours of deliberations Tuesday, asking for a definition of "fraudulent intent" and what it meant legally when the pharma bad boy talked up his assets under management to investors.  

  8. July 28, 2017

    Shkreli Called A 'Con Man' As Fraud Case Heads To Jury

    A prosecutor on Friday made the government's final pitch to the jury weighing the fate of "pharma bro" Martin Shkreli over securities fraud and conspiracy charges, saying that the former CEO of Retrophin Inc. and Turing Pharmaceuticals is nothing but a con man.

  9. July 27, 2017

    Feds Call Shkreli A Liar As Defense Denies Any Fraud

    Jurors weighing the fate of Martin Shkreli heard closing arguments Thursday in the government's securities fraud case against the controversial "pharma bro," with the prosecution claiming his businesses were built on a web of lies and the defense saying no investors were defrauded.

  10. July 26, 2017

    Shkreli Loses Bid To Nix Charges After Resting Case

    Attorneys for former Turing Pharmaceuticals and Retrophin CEO Martin Shkreli on Wednesday rested their case without calling any witnesses to testify at his securities fraud trial over allegations he defrauded investors and paid them off with looted company funds, and lost a long-shot bid to dodge the charges.